Key result
QiShenYiQi Pills relieved fatigue-induced cardiac hypertrophy and enhanced heart function in a rat model, potentially by improving energy metabolism through IGF-1R signaling regulation.
Why the study?
Prolonged exercise can adversely affect cardiac function, but whether QiShenYiQi Pills can ameliorate fatigue-induced cardiac hypertrophy through energy regulation was unknown.
Does QiShenYiQi Pills (QSYQ) ameliorate fatigue-induced cardiac hypertrophy and dysfunction in a rat model?
Population
Male Sprague-Dawley rats in an exercise adaptation and fatigue model
Comparison
QiShenYiQi Pills vs control in fatigue-induced cardiac hypertrophy
Design
Animal experimental study
Authors
Loading...
QSYQ may mitigate fatigue-induced hypertrophy in rats; leaves open human relevance and requires clinical trials.
Does QiShenYiQi Pills (QSYQ) ameliorate fatigue-induced cardiac hypertrophy and dysfunction in a rat model?
In a rat model, QiShenYiQi Pills ameliorated fatigue-induced cardiac hypertrophy and dysfunction by regulating energy metabolism via IGF-1R signaling.
Huang et al. (2019) studied Fatigue-induced cardiac hypertrophy. QiShenYiQi Pills (QSYQ) vs. Fatigue model without QSYQ was evaluated on Cardiac hypertrophy and heart function. QiShenYiQi Pills relieved fatigue-induced cardiac hypertrophy and enhanced heart function in a rat model, potentially by improving energy metabolism through IGF-1R signaling regulation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: